Epidemiological and etiological features and the current state of the problem of treating chronic cystitis (literature review)

Authors

DOI:

https://doi.org/10.26641/2307-5279.28.1-4.2024.322085

Keywords:

chronic cystitis, lower urinary tract infections, bladder, kidneys, genitals

Abstract

Epidemiological and etiological features and the current state of the problem of treating chronic cystitis (literature review)

References

Albert, X., Huertas, I., Pereiró, I. I., Sanfélix, J., Gosalbes, V., & Perrota, C. (2004). Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev., 3, CD001209. https://doi.org/10.1002/14651858.CD001209.pub2

Anger, J., Lee, U., Ackerman, A. L., Chou, R., Chughtai, B., Clemens, J. Q., & et al. (2019). Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU Guideline. J Urol., 202(2), 282-289. https://doi.org/10.1097/JU.0000000000000296

Biloruskyi, B. O., & Stroi, O. O. (2017). Suchasni pidkhody do likuvannya khronichnoho tsystytu u zhinok. [Modern approaches to the treatment of chronic cystitis in women.]. Liky Ukrainy, 5(211), 33-35.

Birder, L. A., & de Groat, W. C. (2007). Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat. Clin. Pract. Urol. 4(1), 46–54. https://doi.org/10.1038/ncpuro0672

Bleidorn, J., Gágyor, I., Kochen, M. M., Wegschei¬der, K., & Hummers-Pradier, E. (2010 May 26). Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? – results of a randomized controlled pilot trial. BMC Med., 8(30). https://doi.org/10.1186/1741-7015-8-30

Bonkat, G., Bartoletti, R., Bruyère, F., & et al. (2021). EAU Guidelines on urological infections. European Association of Urology, 74 p.

Brubaker, L., Carberry, C., Nardos, R., Carter-Brooks, C., & Lowder, J. L. (2018). American Urogynecologic Society best-practice statement: recurrent urinary tract infection in adult women. Female Pelvic Med Reconstr Surg., 24(5), 321–335. https://doi.org/10.1097/SPV.0000000000000550

Bunn, F., Kirby, M., Pinkney, E., & et al. (2015). Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int. J. Clin. Pract., 69(2), 199-217. https://doi.org/10.1111/ijcp.12518

Calleja-Agius, J., & Brincat, M. P. (2015). The urogenital system and the menopause. Climacteric, 18 (Suppl 1), 18-22. https://doi.org/10.3109/13697137.2015.1078206

Chen, A., Shahiyan, R. H., & Anger, J. T. (2022 Jan). Interstitial Cystitis/Bladder Pain Syndrome Treatment: A Systematic Review of Sexual Health Outcomes. Sex Med Rev.,10(1), 71-76. https://doi.org/10.1016/j.sxmr.2020.12.005

Chen, P.-Y., Lee, W.-C., & Chuang, Y.-C. (2021). Comparative safety review of current pharmacological treatments for interstitial cysti¬tis/bladder pain syndrome. Expert Opin Drug Saf. Sep, 20(9), 1049-1059. https://doi.org/10.1080/14740338.2021.1921733

Chermansky, C.J., & Guirguis, M. O. (2022 May). Pharmacologic Management of interstitial cystitis/bladder pain syndrome. Urol Clin North Am., 49(2):273-282. https://doi.org/10.1016/j.ucl.2022.01.003

Chiavaroli, C., & Moore, A. (2006). An hypothesis to link the opposing immunological effects induced by the bacterial lysate OM-89 in urinary tract infection and rheumatoid arthritis. BioDrugs., 20(3), 141-149. https://doi.org/10.2165/00063030-200620030-00001

Ciani, O., Arendsen, E., Romancik, M., Lunik, R., Costantini, E., Di Biase, M., Morgia, G., Fragalà, E., Tomaskin, R., Bernat, M., Guazzoni, G., Tarricone, R., & Lazzeri, M. (2016 Mar 31). In¬travesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract in-fections: a European multicentre nested case-control study. BMJ Open., 6(3), e009669. https://doi.org/10.1136/bmjopen-2015-009669

Cicione, A., Cantiello, F., Ucciero, G., Salonia, A., & et al. (2014). Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations. Int. J. Urol., 21(8), 763-768. https://doi.org/10.1111/iju.12430

Constantinides, C., Manousakas, T., Nikolopou-los, P., Stanitsas, A., Haritopoulos K., & Giannopoulos, A. (2004 Jun). Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int., 93(9), 1262-1266.

https://doi.org/10.1111/j.1464-410X.2004.04850.x

Coudeyras, S., Jugie, G., Vermerie, M., & Fore-stier, C. (2008). Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect Dis Obstet Gynecol., 2008, 549640. https://doi.org/10.1155/2008/549640

Daneman, N., Chateau, D., Dahl, M., & et al. (2020). Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study. Clinical Microbiology and Infection, 26(5), 613-618. https://doi.org/10.1016/j.cmi.2019.10.016

Dason, S., Dason, J. T., & Kapoor, A. (2011). Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J., 5(5):316-322. https://doi.org/10.5489/cuaj.687

EARSS: European antimicrobial resistance sur-veillance system (2002–2007).

Elbadawi, A. E., & Light, J. K. (1996). Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis. Urol Int., 56(3), 137-162. https://doi.org/10.1159/000282832

Escribá, F. D., Talero, T. S., & Pérez, G. R. (1991 Jun) The role of E. coli adhesins in the pathogenesis of urinary infection. Rev Clin Esp., 189(1), 8-13.

Falagas, M. E., Vouloumanou, E. K., Togias, A. G., Karadima, M., Kapaskelis, A. M., Rafailidis, P. I., & et al. (2010). Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trial. J Antimicrob Chemother, 65(9):1862-1877. https://doi.org/10.1093/jac/dkq237

Foxman, B. (2002). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med,113 (Suppl 1A), 5S-13S. https://doi.org/10.1016/S0002-9343(02)01054-9

Foxman, B. (2003 Feb). Epidemiology of urinary tract infections: incidence, morbidity, and eco-nomic costs. Dis Mon., 49(2), 53-70. https://doi.org/10.1067/mda.2003.7

Foxman, B. (2014 Mar). Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am., 28(1), 1-13. https://doi.org/10.1016/j.idc.2013.09.003

Foxman, B., Barlow, R., d’Arcy, H., Gillespie, B., & Sobel, J. D. (2000 Nov). Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol., 10(8), 509-515. https://doi.org/10.1016/s1047-2797(00)00072-7

Gaber, M. (1981 Jul). Female relative hypospadias: clinicopathologic features. Urology, 18(1), 27-31. https://doi.org/10.1016/0090-4295(81)90490-8

Giannantoni, A., Bini, V., Dmochowski, R., Hanno, P., Nickel, J. C., Proietti, S., & Wyndaele, J. J. (2012). Contemporary management of the painful bladder: a systematic review. European Urology, 1(61), 29-53. https://doi.org/10.1016/j.eururo.2011.07.069

Grabe, M. & et al. (2015). EAU Guidelines on Urological Infections

Grabe, M., Bjerklund Johansen, T. E., Botto, H., Cek, M., Naber, K. G., Tenke, P., & Wagenlehner, F. M. E. (2011). Guidelines on urological in¬fections. In: Urology EAo, editor. European Asso¬ciation of Urology guidelines. Arnhem, Netherlands: European Association of Urology, 112 p.

Grover, S., Srivastava, A., Lee, R., & et al. (2011). Role of inflammation in bladder function and interstitial cystitis. Ther. Adv. Urol. 3(1), 19-33. https://doi.org/10.1177/1756287211398255

Guay, D. R. P. (2009). Cranberry and urinary tract infections. Drugs, 69(7), 775-807. https://doi.org/10.2165/00003495-200969070-00002

He, C., Fan, K., Hao, Z., Tang, N., Li, G., & Wang, S. (2022 Jun 21). Prevalence, Risk Factors, Pathophysiology, Potential Biomarkers and Mana¬gement of Feline Idiopathic Cystitis: An Update Review. Front Vet Sci., (9), 900847. https://doi.org/10.3389/fvets.2022.900847

Hooton, T. M. (2012). Clinical practice. Uncomplicated urinary tract infection. N Engl J Med, (366), 1028-1037. https://doi.org/10.1056/NEJMcp1104429

Hooton, T. M., Bradley, S. F., Cardenas, D. D., Colgan, R., Geerlings, S. E., Rice, J. C., & et al. (2010). Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Gui¬delines from the Infectious Diseases Society of America. Clin Infect Dis, 50, 625-663. https://doi.org/10.1086/650482

Hsu, C. Y., Lin, C. L., & Kao, C. H. (2020). Association between Chronic Interstitial Cystitis and Herpes Zoster. Int J Environ Res Public Health., 17(7), 2228. https://doi.org/10.3390/ijerph17072228

Huber, M., Krauter, K., Winkelmann, G., Bauer, H. W., Rahlfs, V. W., Lauener, P. A., Blessmann, G. S., & Bessler, W. G. (2000 Dec). Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89. Int J Immunopharmacol., 22(12), 1103-111. https://doi.org/10.1016/s0192-0561(00)00070-9

Iremashvili, V. V. (2008). Infektsii mochevyvo-dyashchikh putey: sovremennyy vzglyad na problemu [Urinary tract infections: a modern view of the problem]. Zdorov’e muzhchiny, (1), 38-41.

Jhang, J. F., Hsu, Y. H., Peng, C. W., Jiang, Y. H., Ho, H. C., & Kuo, H. C. (2018). Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cysti¬tis/Bladder Pain Syndrom. J. Urol., 200(3):590-596. https://doi.org/10.1016/j.juro.2018.03.133

Jones, C. A., & Nyberg, L. (1997). Epidemiology of interstitial cystitis. Urology, 49(5A Suppl), 2. https://doi.org/10.1016/S0090-4295(99)80327-6

Kallestrup, E. B., Jorgensen, S. S., Nordling, J., & Hald, T. (2005). Treatment of interstinal cystitis with Cystistat: a hyaluronic acid product. Scand. J. Urol. Nephrol., 39(2), 143-147. https://doi.org/10.1080/00365590410015876-1

Kaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., & et al. (2018). Effect of Meropenem-Vaborbactam vs PiperacillinTazobactam on Clinical Cure or Impro¬vement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA, 319(8), 788-799. https://doi.org/10.1001/jama.2018.0438

Kim, A., Lim, D., Song, M., & Choo, M.-S. (2014). Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instilation in Refractory Interstitial Cystitis/ Painful Bladder Syndrome. Int. Neurourol. J. 18, 163-167. https://doi.org/10.5213/inj.2014.18.3.163

Kranjčec, B., Papeš, D., & Altarac, S. (2014 Feb). D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol., 32(1):79-84. https://doi.org/10.1007/s00345-013-1091-6

Kwok, M., McGeorge, S., Mayer-Coverdale, J., Graves, B., Paterson, D. L., Harris, P. N. A., Esler, R., Dowling, C., Britton, S., & Roberts, M. J. (2022 Nov). Guideline of guidelines: management of recurrent urinary tract infections in women. BJU Int., 130(Suppl 3), 11-22. https://doi.org/10.1111/bju.15756

Lazzeri, M., & Montorsi, F. (2011 Jul). The thera-peutic challenge of "chronic cystitis": search well, work together, and gain results. Eur Urol., 60(1):78-80. https://doi.org/10.1016/j.eururo.2011.03.039

Lee, G., Romih, R., & Zupančič, D. (2014). Cystitis: from urothelial cell biology to clinical applications. Biomed Res. Int. 2014. https://doi.org/10.1155/2014/473536

Lee, P. J., & Kuo, H. C. (2020). High incidence of lower urinary tract dysfunction in women with recurrent urinary tract infections. Low Urin Tract Symptoms., 12(1):33-40. https://doi.org/10.1111/luts.12280

Liulko, A. V., Volkova, L. N., & Sukhodols-kaia, A. E. (1988). Tsistit [Cystitis]. Kyiv: Zdo¬rov'e, 176 p.

Maskell, R. M. (2010 May). The natural history of urinary tract infection in women. Med Hypotheses., 74(5):802-806. https://doi.org/10.1016/j.mehy.2009.12.011

Mauro, C., & Natale, F. (2014). Gynecological di-sorders in bladder pain syndrome/interstitial cystitis patients. International Urology and Nephro¬logy, 21(1). 85-88. https://doi.org/10.1111/iju.12379

Meijlink, J. M. (2014). Interstitial cystitis and the painful bladder: A brief history of nomenclature, definitions and criteria. International Journal of Urology, 21, 4-12. https://doi.org/10.1111/iju.12307

Meng, E., Hsu, Y-Ch., & Chuang, Y-Ch. (2018 Jan). Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC). Low Urin Tract Symptoms., 10(1):3-11. https://doi.org/10.1111/luts.12214

Mishell, D. R. Jr. (2006 Mar). Chronic pelvic pain in women: Focus on painful bladder syndro-me/lnter¬stitial cystitis. J Reprod Med., 51(Suppl 3), 225-226.

Morales, A., Emerson, L., & Nickel, J. C. (1997). Intravesical hyaluronic acid sn the treatment of refractory cystitis. Urology, 49(Suppl 5A), 111. https://doi.org/10.1016/S0090-4295(97)00183-0

Motsch, J., Murta de Oliveira, C., Stus, V., Kök-sal, I., Lyulko, O., Boucher, H. W., Kaye, K. S., File, T. M., Brown, M. L., Khan, I., Du, J., Joeng, H. K., Tipping, R. W., Aggrey, A., Young, K., Kartsonis, N. A., Butterton, J. R., & Paschke, A. (2020 Apr 15). RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Com¬paring Efficacy and Safety of Imipe¬nem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. Clin Infect Dis., 70(9):1799-1808. https://doi.org/10.1093/cid/ciz530. PMID: 31400759, PMCID: PMC7156774.

Mumm, J. N., Osterman, A., Ruzicka, M., Stihl, C., Vilsmaier, T., Munker, D., Khatamzas, E., Giessen-Jung, C., Stief, C., Staehler, M., & Rodler, S. (2020). Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol., 78(4):624-628. https://doi.org/10.1016/j.euru-ro.2020.05.013

Naber, K. G., Alidjanov, J. F., Dekthiar, Y. M., Molchanov, R. M., Sonnyk, E. G., Pasiechni-kov, S. P., Samchuk, P., Stus, V. P., Hav-va, N. V., Anto¬nyan, I. M., Pilatz, A., & Wagenlehner, F. M. E. (2022). Ukrainian Version of the Acute Cystitis Symptom Score (ACSS) for Diagnostics and Patient-Reported Outcome of Acute Uncomplicated Cystitis. Part I. Linguistic validation and Cognitive assessment. Urologiya, 26(1), 5-11. https://doi.org/10.26641/2307-5279.26.1.2022.260442

Naber, K. G., Schito, G., Botto, H., Palou, J., & Mazzei, T. (2008). Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol, 54(5):1164-1175. https://doi.org/10.1016/j.eururo.2008.05.010

Nicolle, L. E. (2005). Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol., 16, 349-360. https://doi.org/10.1155/2005/385768

Nicolle, L. E., Bradley, S., Colgan, R., Rice, J. C., Schaeffer, A., & Hooton, T. M. (2005). Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis, (40), 643-654. https://doi.org/10.1086/427507

Nicolle, L. E., Gupta, K., Bradley, S. F., & et al. (2019). Clinical practice guideline for the mana¬gement of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis., 68(10):1611-1615. https://doi.org/10.1093/cid/ciz021

Nikitin, O. D. (2015). Suchasnyi pidkhid do infravezykalnoi terapii khronichnoho tsystytu [The modern approach to intravesical therapy of chronic cystitis]. Health of Man, 4(55), 17–22. https://doi.org/10.30841/2307-5090.4(55).2015.104493

Palacios-Baena, Z. R., Giannella, M., Manissero, D., & et al. (2021). Risk factors for carbapenem-resistant Gram-negative bacterial infections: a sys¬tematic review. Clin. Microbiol. Infect. 27, 228-235. https://doi.org/10.1016/j.cmi.2020.10.016

Parazzini, F., Ricci, E., Fedele, F., Chiaffarino, F., Esposito, G., & Cipriani, S. (2022 Jun 15). Systematic review of the effect of D-mannose qwith or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed Rep., 17(2), 69. https://doi.org/10.3892/br.2022.1552

Parsons, C. L. (2002). Chronic cystitis: epidemiology and clinical presentation. Clin Obstet Gynecol, (45), 242. https://doi.org/10.1097/00003081-200203000-00025

Parsons, C. L., Stein, P. C., Bidair, M., & Lebow, D. (1994). Abnormal sensitivity to intravesical potas¬sium in interstitial cystitisand radiation cystitis. Neurourol Urodynamics, (13), 515. https://doi.org/10.1002/nau.1930130503

Pasiechnikov, S. P. (2011). Urolohiya. Diyuchi protokoly nadannya medychnoyi dopomohy [Urology. Current medical care protocols]. Kyiv: TOV “Doktor-Medi”, 626 p.

Pasiechnikov, S. P. (2016). Tsystyt: etiopatohenez, klasyfikatsiya, klinichna kartyna, diahnostyka, likuvannya [Cystitis: etiopathogenesis, classifi¬cation, clinical picture, diagnostics, treatment]. Ukrainskyi medychnyi chasopys, 114(4), 34–37. https://umj.com.ua/uk/publikatsia-99100-tsistit-etiopatogenez-klasifikatsiya-klinichna-kartina-diagnostika-likuvannya

Pierce, A. N., & Christianson, J. A. (2015). Stress and chronic pelvic pain. Prog. Mol. Biol. Transl. Sci. 131, 509-535. https://doi.org/10.1016/bs.pmbts.2014.11.009

Raz, R., Chazan, B., Kennes, Y., Colodner, R., Rottensterich, E., Dan, M., Lavi, I., & Stamm, W. (2002 May 1). Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis., 34(9):1165-9. https://doi.org/10.1086/339812

Robles, M. T. S., Cantalupo, P. G., Duray, A. M., Freeland, M., Murkowski, M., van Bokhoven, A., Stephens-Shields, A. J., Pipas, J. M., & Impe¬riale, M. J. (2020). Analysis of viruses present in urine from patients with interstitial cystitis. Virus Genes.,56(4), 430-438. https://doi.org/10.1007/s11262-020-01767-z

Rosen, J. M., & Klumpp, D. J. (2014). Mechanisms of pain from urinary tract infection. Int. J. Urol., 21I(Suppl 1), 26-32. https://doi.org/10.1111/iju.12309

Sanford, M. T., & Rodriguez, L. V. (2017). The role of environmental stress on lower urinary tract symptoms. Curr. Opin. Urol., 27(3), 268-273. https://doi.org/10.1097/MOU.0000000000000379

Shigehara, K., Sasagawa, T., & Namiki, M. (2014). Human papillomavirus infection and pathogenesis in urothelial cells: a mini-review. J Infect Chemother., 20(12):741-747. https://doi.org/10.1016/j.jiac.2014.08.033

Siddiqui, H., Lagesen, K., Nederbragt, A. J., Jeansson, S. L., & Jakobsen, K. S. (2012). Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiology, 12(9), 205 p.

Singh,S., van Herwijnen, I., & Phillips, C. (2013). The management of lower urogenital changes in the menopause. Menopause Int., 19(2), 77-81. https://doi.org/10.1177/1754045313481536

Sonal, G., Abhishek, S., Richard, L., & Ashutosh, K. T. (2011). Role of inflammation in bladder function and interstitial cystitis. Therapeutic Advances in Urology, 3(1), 19-33. https://doi.org/10.1177/1756287211398255

Speer, L. M., Mushkbar, S., & Erbele, T. (2016). Chronic pelvic pain in women. Am. Fam. Physician., 93(5), 380-387.

Stus, V. P., Rusinko, I. M., Ukrainets, E. P., Krasnov, V. N. & et al. (2015). Rol preparatov gialu¬ronovoi kisloty v kompleksnom lechenii khroni¬cheskoho tsistita [The role of hyaluronic acid preparations in the complex treatment of chronic cystitis]. Urologíya, 19(3), 331–333.

Tamma, S. M., Shorter, B., Toh, K. L. & et al. (2015). Influence of polyunsaturated fatty acids on urologic inflammation. Int. Urol. Nephrol. 47(11), 1753-1761. https://doi.org/10.1007/s11255-015-1108-8

Tenke, P., Köves, B., Nagy, K., Hultgren, S. J., Mendling, W., Wullt, B., Grabe, M., Wagen-lehner, F. M. E., Cek, M., Pickard, R., Botto, H., Naber, K. G., & Johansen, T. E. B. (2012 Feb). Up¬date on biofilm infections in the urinary tract. World J Urol., 30(1), 51-57. https://doi.org/10.1007/s00345-011-0689-9

Thomas-White, K., Navarro, P., Wever, F., King, L., Dillard, L. R., & Krapf, J. (2023 Jan-Dec). Psychosocial impact of recurrent urogenital infec¬tions: a review. Womens Health (Lond), (19), 17455057231216537. https://doi.org/10.1177/17455057231216537

Vautrin, N., Dahyot, S., Leoz, M., Caron, F., Grand, M., Feldmann, A., Gravey, F., Legris, S., Ribet, D., Alexandre, K., & Pestel-Caron, M. (2023 Nov). Are Escherichia coli causing recurrent cystitis just ordinary Uropathogenic E. coli (UPEC) strains? bioRxiv. 9, 2023.11.08.566351. https://doi.org/10.1101/2023.11.08.566351

Vozianov, O. F., Liulko, O. V. (2001). Atlas-kerivnytstvo z urolohii [Atlas-guide to urology]. Dnipropetrovsk: RVA “Dnipro-VAL”, 2, 674 p.

Wade, D., Cooper, J., Derry, F., & Taylor, J. (2019). Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study. Trials., 20(1), 223. https://doi.org/10.1186/s13063-019-3275-x

Wagenlehner, F. M. (2021). New antibiotics in the treatment of urinary tract infections. Urologiya, 25(2), 97-101.

https://doi.org/10.26641/2307-5279.25.2.2021.238219

Wagenlehner, F. M. E., Bjerklund, J. T. E., Cai, T., Koves, B., Kranz, J., Pilatz, A., & et al. (2020). Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol., 17(10), 586–600. https://doi.org/10.1038/s41585-020-0362-4

Wagenlehner, F. M. E., Vahlensieck, W., Bauer, H. W., Weidner, W., Piechota, H. J., & Naber, K. G. (2013 Mar). Prevention of recurrent urinary tract infections. Minerva Urol Nefrol., 65(1), 9-20.

Wagenlehner, F. M., Abramov-Sommariva, D., Martina, Höller M., Steindl, H., & Naber, K. G. (2018). Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomi¬zed, Multicentre, Non-Inferiority Phase III Trial. Urol. Int., 101(3), 327-336. https://doi.org/10.1159/000493368

Wagenlehner, F. M., Hoyme, U., Kaase, M., Funfstuck, R., Naber, K. G., & Schmiemann, G. (2011). Uncomplicated urinary tract infections. Dtsch Arztebl Int, (108), 415-423. https://doi.org/10.3238/arztebl.2011.0415

Wagenlehner, F., Wullt, B., Ballarini, S., Zingg, D., Naber, K. G. (2018). Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res., 18(1):107-117. https://doi.org/10.1080/14737167.2017.1359543

Wang, X., Liu, W., O'Donnell, M., Lutgendorf, S., Bradley, C., Schrepf, A., Liu, L., Kreder, K., & Luo, Y. (2016 Dec 21). Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Net-work Animal Model Study. PLoS One., 11(12):e0168772. https://doi.org/10.1371/journal.pone.0168772

Yosef, A., Allaire, C., Williams, C. & et al. (2016). Multifactorial contributors to the severity of chronic pelvic pain in women. Am. J. Obstet. Gynecol., 215(6). https://doi.org/10.1016/j.ajog.2016.07.023

Downloads

Published

2024-12-30

Issue

Vol. 28 No. 1-4 (2024)

Section

Urology

License

Стаття повинна мати візу керівника та офіційне направлення від установи, з якої виходить стаття (з круглою печаткою), і вказівкою, чи є стаття дисертаційною, а також у довільній формі на окремому аркуші - відомості про авторів (прізвище, ім’я, по батькові, посада, вчений ступінь, місце роботи, адреса, контактні телефони, E-mail).

Стаття повина бути підписана всіма авторами, які укладають з редакцією договір пропередачу авторських прав (заповнюється на кожного автора окремо з оригінальним підписом). За таких умов редакція має право на її публікацію та розміщення на сайті видавництва.